title: [Sideropenia: modality and length of therapy].
authors.forename: L
authors.initials: L
authors.lastname: Ottaiano
authors.forename: E
authors.initials: E
authors.lastname: Ravazzolo
authors.forename: L
authors.initials: L
authors.lastname: Elia
authors.forename: T
authors.initials: T
authors.lastname: Sansolini
authors.forename: G D
authors.initials: GD
authors.lastname: Di Nucci
authors.forename: B
authors.initials: B
authors.lastname: Monarca
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000747:Anemia, Hypochromic / Q000188:drug therapy*; D002807:Chondroitin / Q000031:analogs & derivatives*; D002809:Chondroitin Sulfates / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013997:Time Factors
chemical_list: D002807:Chondroitin; D002809:Chondroitin Sulfates
vernacular_title: Malattia sideropenica: modalità e durata di terapia.